Current evidence supports prescription icosapent ethyl in selected statin-treated patients with persistent hypertriglyceridemia, with treatment guided by cardiovascular risk, formulation, and dose rather than considering omega-3 preparations as an interchangeable class.
S. Finocchiaro, L. Cutore, C. Bordonaro et al.· Cardiovascular Drugs and The...· 0 citations
INTRODUCTION
Acute coronary syndrome (ACS) remains a leading cause of morbidity and mortality worldwide. Sex- and gender-related differences in ACS persist and encompass risk profiles, clinical presentation, management, and outcomes.
AREAS COVERED
PubMed was searched from database inception through May 2026 for relev...
K. Bujak, C. Bordonaro, M. S. Mauro et al.· Expert Review of Cardiovascu...· 0 citations
Importance
In patients with atrial fibrillation (AF), oral anticoagulation (OAC) is the gold standard for preventing ischemic stroke, at the expense of a higher risk of bleeding. Catheter-based left atrial appendage closure (LAAC) has been proposed as an alternative strategy to prevent stroke, but the efficacy and safe...
C. Laudani, K. Bujak, D. Giacoppo et al.· JAMA cardiology· 1 citation
In elderly and frail patients with AF, DOACs represent the first-line anticoagulant therapy when appropriately dosed and monitored, and future trials specifically enrolling very old and severely frail patients are urgently needed to close existing evidence gaps.
L. Scalia, Laura Gatto, Federica Agnello et al.· American Journal of Cardiolo...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.